ASCO Reading Room | Immunotherapies in ALL: What’s Best and What’s Next? MedPage Today, 06 Mar 2019 Chimeric antigen receptor (CAR) T cells offer a better chance of remission in relapsed/refractory pediatric and adult B-lineage…